Bibliografía y lecturas recomendadas

• Alberts, B. (1983). Molecular biology of the cell (New York: Garland Pub.).
• Bonavida, B., Garbán, H., Uslu, R., Morimoto, H., and Mizutani, Y. (1998). Cytokine-drug interactions and the potential for integrated therapies. In Ovarian Cancer 5, F. Sharp, T. Blackett, J. Berek and R. Bast, eds. (Oxford, UK: Isis Medical Media Ltd.), pp. 373-384.
• Councilman, W. (1890). Report on the etiology and prevention of yellow fever. In Public Health Bulletin, G. Sternberg, ed. Washington, DC, pp. 151-159.
• Davis, B. D., and American Academy of Arts and Sciences. (1991). The Genetic revolution : scientific prospects and public perceptions (Baltimore: Johns Hopkins University Press).
• Dube, S., Love, J. L., Dube, D. K., Leon-Ponte, M., de Perez, G. E., Baroja, M. L., Bianco, N., and Poiesz, B. J. (1999). The complete genomic sequence of an HTLV-II isolate from a Guahibo Indian from Venezuela. Virology 253, 181-92.
• Garban, H. J., and Bonavida, B. (1999). Nitric oxide sensitizes ovarian tumor cells to Fas-induced apoptosis. Gynecol Oncol 73, 257-64.
• Hesketh, R. (1997). The oncogene and tumour suppressor gene factsbook, 2nd Edition (San Diego: Academic Press).
• Kerr, J. F., Wyllie, A. H., and Currie, A. R. (1972). Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26, 239-57.
• Márquez, D. C., and Pietras, R. J. (2000). Estrogen receptors in plasma membrane regulate growth of human breast cancer cells. Proceedings of the American Association for Cancer Research Annual Meeting, 140.
• Mendible, J. C. (1997). Acidos Nucléicos: La Guia/Desde el descubrimiento del DNA hasta nuestra amiga DOLLY. In Cátedra de Bioquímica. Escuela "Luis razetti".Facultad de Medicina (Caracas: Universidad Central de Venezuela), pp. 133.
• Mueller, R. F., Young, I. D., and Emery, A. E. H. (1998). Emery's elements of medical genetics, 10th Edition (Edinburgh ; New York: Churchill Livingstone).
• Pietras, R. J., Marquez, D., Chen, C., Li, D., and Lin, T. (1999). Antitumor effects of peptide antiestrogens that block estrogen receptor binding to steroid receptor coactivator-1 and to DNA in human breast cancer cells. Proceedings of the American Association for Cancer Research Annual Meeting 40, 637.
• Rathmell, J. C., and Thompson, C. B. (1999). The central effectors of cell death in the immune system. Annu Rev Immunol 17, 781-828.
• Rieber, M., and Strasberg Rieber, M. (2000). Tumor suppression without differentiation or apoptosis by antisense cyclin D1 gene transfer in K1735 melanoma involves induction of p53, p21WAF1 and superoxide dismutases. Proceedings of the American Association for Cancer Research Annual Meeting, 8.
• Schulte, P. A., and Perera, F. P. (1993). Molecular epidemiology : principles and practices (San Diego: Academic Press).
• Sidransky, D., and Stix, G. (1996). Advances in cancer detection. In Scientific American, pp. 104.
• Trent, R. J. (1997). Molecular medicine : an introductory text, 2nd Edition (New York: Churchill Livingstone).
• Wallis, C. (1998). Molecular revolution; a new generation of drugs takes aim at the very heart of cancer - the abnormal genes that make cells malignant in the first place. In Time, pp. 48.
• Weinberg, R. A. (1996). How cancer arises. In Scientific American, pp. 62.
• Zabaleta, M., Peralta, J., Birges, J., Bianco, N., and Echeverria de Perez, G. (1994). HTLV-I-associated myelopathy in Venezuela [letter]. J Acquir Immune Defic Syndr 7, 1289-90.